EPID-25 GERMLINE POLYMORPHISMS IN MGMT INCREASE ABILITY TO MODEL TEMOZOLOMIDE (TMZ)-RELATED MYELOTOXICITY RISK IN PATIENTS WITH GLIOBLASTOMA (GBM) TREATED ON NRG ONCOLOGY/RTOG 0825

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Scheurer, Michael E., Zhou, Renke, Gilbert, Mark R., Bondy, Melissa L., Sulman, Erik P., Yuan, Ying, Liu, Yanhong, Vera-Bolanos, Elizabeth, Wendland, Merideth M., Brachman, David G., Stieber, Volker W., Komaki, Ritsuko R., Flickinger, John C., Kenyon, Lawrence C., Robins, H. Ian, Hunter, Grant K., Crocker, Ian R., Chao, Samuel T., Stella, Philip J., Pugh, Stephanie L., Armstrong, Terri
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2015
Konular:
Abstracts from the 20th Annual Scientific Meeting of the Society for Neuro-Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4638765/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov213.25
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller